NCT05642962 2026-02-25
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
Memorial Sloan Kettering Cancer Center
Phase 1/2 Active not recruiting
Clinical Trials
3 trialsNCT02985801 2021-03-15
PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer
Mayo Clinic
Phase 1/2 Terminated
NCT03469258 2020-08-03
Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma
Dana-Farber Cancer Institute
Phase 2 Terminated